Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current earnings are HK$13.98 Billion. In 2023 the company made an earning of HK$1.03 Billion, an increase over its 2022 earnings that were of -HK$19.49 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.